Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention: results from the ARMYDA-2 (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) study.

G, Patti; G, Colonna; V, Pasceri; LL, Pepe; A, Montinaro; Sciascio G, Di

doi:10.1161/01.cir.0000161383.06692.d4

Public

Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention: results from the ARMYDA-2 (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) study.

Shared by NobleBlocks on Mar 6, 2005 • 12:00 AM UTC

Authors:

Patti G

Colonna G

Pasceri V

Abstract

<h4>Background</h4>Aggressive platelet inhibition is crucial to reduce myocardial injury and early cardiac events after coronary intervention. Although observational data have suggested that pretreatment with a high loading dose of clopidogrel may be more effective than a conventional dose, this hyp...

Discussions